TAK-771-4004: Maternal and Infant Characteristics and Outcomes Following Exposure to HyQvia During Pregnancy: A Case Series Study Based on US Claims Data

First published 16/03/2023

Last updated 23/04/2024

EU PAS number:

EUPAS103800

Study

Finalised

Documents

Study protocol

Initial protocol

TAK-771-4004-clinical-study-protocol-redact

English (1.21 MB - PDF) View document

Study results

TAK-771-4004‐clinical‐study‐report‐redact

English (751.29 KB - PDF) View document

Study report

Other information

Secondary tabs